Han Lili, Liu Jing, Shataer Mireayi, Wu Chengyong, Niyazi Mayinuer
Department of Gynecology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumchi, Xinjiang, China.
Cancer Biol Ther. 2024 Dec 31;25(1):2322207. doi: 10.1080/15384047.2024.2322207. Epub 2024 Mar 11.
was reported to be a hotspot gene in cervical cancer. The relationship between genetic polymorphisms and cervical cancer has not been reported. Genetic factors influence the occurrence of cervical cancer. Thus, we explored the correlation between polymorphisms and cervical cancer.
A total of 973 participants within 494 cervical cancer cases and 479 healthy controls were recruited. Five single nucleotide polymorphisms (SNPs) in the gene were genotyped using the Agena MassARRAY platform. Chi-squared test, logistic regression analysis, odds ratio (OR), multifactor dimensionality reduction (MDR), and 95% confidence interval (95%CI) were used for data analysis.
In the overall analysis, rs16902094 ( = .014, OR = 1.86, 95% CI = 1.12-3.08) and rs16902104 ( = .014, OR = 1.86, 95% CI = 1.12-3.09) had the risk-increasing correlation with the occurrence of cervical cancer. Stratification analysis showed that rs16902094 and rs16902104 were still associated with cervical cancer risk in the subgroups with age > 51, BMI < 24 kg/m, smokers, and patients with cervical squamous cell carcinoma. MDR analysis displayed that rs16902094 (.49%) and rs16902104 (.52%) were the main influential attribution factor for cervical cancer risk.
Our finding firstly determined that two SNPs (rs16902094, rs16902104) were associated with an increased risk of cervical cancer, which adds to our knowledge regarding the effect of on cervical carcinogenesis.
据报道,[基因名称]是宫颈癌中的一个热点基因。该基因的遗传多态性与宫颈癌之间的关系尚未见报道。遗传因素影响宫颈癌的发生。因此,我们探讨了[基因名称]多态性与宫颈癌之间的相关性。
共纳入494例宫颈癌病例和479例健康对照中的973名参与者。使用Agena MassARRAY平台对该基因中的5个单核苷酸多态性(SNP)进行基因分型。采用卡方检验、逻辑回归分析、比值比(OR)、多因素降维法(MDR)和95%置信区间(95%CI)进行数据分析。
在总体分析中,rs16902094(P = 0.014,OR = 1.86,95%CI = 1.12 - 3.08)和rs16902104(P = 0.014,OR = 1.86,95%CI = 1.12 - 3.09)与宫颈癌的发生呈风险增加的相关性。分层分析表明,在年龄>51岁、体重指数(BMI)<24kg/m²、吸烟者和宫颈鳞状细胞癌患者的亚组中,rs16902094和rs16902104仍与宫颈癌风险相关。MDR分析显示,rs16902094(49%)和rs16902104(52%)是宫颈癌风险的主要影响归因因素。
我们的研究首次确定了两个[基因名称]SNP(rs16902094,rs16902104)与宫颈癌风险增加相关,这增加了我们对[基因名称]在宫颈癌发生中的作用的认识。